Daniel Olson
Assistant Professor of Medicine · University of Chicago Medical Center
Credentials: · · · ·
History
- 2017–2019
- 2010–2014
Research
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Journal of Clinical Oncology · 2021 · First of 20 authors · 182 citations
Considerations for treatment duration in responders to immune checkpoint inhibitors
Review · Journal for ImmunoTherapy of Cancer · 2021 · 112 citations
Cancer Immunology Research · 2022 · 81 citations
- JL
9 papers
6 papers
3 papers · 3 as a fellow
- RS
3 papers · 3 as a fellow
- SR
3 papers · 3 as a fellow
3 papers · 3 as a resident
2 papers
2 papers
